FDA Advisers Vote Against Experimental ALS Treatment Pushed by Patients
Federal health advisers voted overwhelmingly against an experimental treatment for Lou Gehrig’s disease at a Wednesday meeting prompted by years of patient efforts seeking access to the unproven therapy. The panel of Food and Drug Administration experts voted 17-1 that …